全部 281 心血管 2,046 高血压 576 心衰 451 心律失常 379 冠心病 310 动脉粥样硬化 281 心肌病 230 血脂 163 心脏瓣膜 66 心血管预防 13

The Complex Role of Methylation in Regulating Vascular Smooth Muscle Cell Phenotypic States in Vascular Remodeling and Atherosclerosis.

Biomolecules 2026-06-02 浏览 30 动脉粥样硬化

Vascular smooth muscle cell (VSMC) control of phenotypic states through regulation of contractile gene expression is critical for vascular homeostasis and for participation in pathological vascular re...

DOI 原文

Anti-Inflammatory Interleukins in the Pathogenesis of Atherosclerosis.

International journal of molecular sciences 2026-06-02 浏览 41 动脉粥样硬化

In recent years, the study of interleukins (ILs), crucial cytokines involved in inflammation, has garnered significant attention within coronary artery disease including atherosclerosis. This review p...

DOI 原文

Regional tissue oxygen saturation as an indicator of wound healing during endovascular treatment for chronic limb-threatening ischaemia.

Journal of wound care 2026-06-02 浏览 56 动脉粥样硬化

OBJECTIVE: It is important to evaluate limb blood flow during the perioperative period to salvage affected limbs in patients with chronic limb-threatening ischaemia (CLTI). However, it is difficult to...

DOI 原文

Metformin as a multi-target modulator of atherosclerosis: integrated regulation of Nrf2/KLF2, mitochondrial homeostasis, inflammation, ferroptosis, and innate immunity.

The Journal of pharmacy and pharmacology 2026-06-02 浏览 63 动脉粥样硬化

OBJECTIVES: Atherosclerosis (AS) is a chronic inflammatory vascular disorder driven by endothelial dysfunction, oxidative stress, lipid dysregulation, mitochondrial injury, and maladaptive immune acti...

DOI 原文

[Mechanistic study of Scutellariae Radix against atherosclerosis through inhibition of pyroptosis based on network pharmacology and experimental verification].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 2026-06-01 浏览 8 动脉粥样硬化

This study systematically investigated the mechanism of Scutellariae Radix against atherosclerosis(AS) through the integrated application of network pharmacology, molecular docking, and animal experim...

DOI 原文

[Mechanism study of Zhizi Dahuang Decoction in treating atherosclerosis based on network pharmacology, molecular docking, and experimental validation].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 2026-06-01 浏览 9 动脉粥样硬化

This paper investigated the effects and mechanisms of Zhizi Dahuang Decoction(ZZDHT) in treating atherosclerosis(AS) through a comprehensive approach combining network pharmacology, molecular docking,...

DOI 原文

Effect of L‑arginine supplementation on homocysteine and asymmetric dimethylarginine in atherosclerotic lower limb ischemia.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 2026-06-01 浏览 17 动脉粥样硬化

Chronic lower limb ischemia is a manifestation of systemic atherosclerosis frequently accompanied by lipid metabolism disorders, endothelial dysfunction, and disturbances in the L-arginine-nitric oxid...

DOI 原文

Targeting atherosclerotic inflammation: Advances in NLRP3 inflammasome inhibitors beyond LDL-C.

Acta pharmaceutica (Zagreb, Croatia) 2026-06-01 浏览 42 动脉粥样硬化

Atherosclerosis, the main pathological background of cardiovascular diseases, is not only characterized by lipid metabolism disorders but also chronic inflammation as a major driver of disease progres...

DOI 原文

Plain balloon angioplasty +/- bare metal stenting versus drug-coated balloon angioplasty +/- bare metal stenting versus primary drug-eluting stenting in patients with chronic limb-threatening ischaemia: BASIL-3, an open-label, three-arm, randomised, multi-centre, phase 3 trial.

Health technology assessment (Winchester, England) 2026-06-01 浏览 33 动脉粥样硬化

OBJECTIVES: To determine which primary endovascular revascularisation strategy represents the most clinical and cost-effective treatment for patients with chronic limb threatening ischaemia who requir...

DOI 原文

[Research advances in the molecular mechanisms of microRNA-mediated macrophage lipid homeostasis and foam cell formation].

Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology 2026-06-01 浏览 32 动脉粥样硬化

The progression of atherosclerosis (AS) is intrinsically associated with dysregulated lipid metabolism in macrophages, leading to the formation of foam cells. MicroRNA (miRNA) finely regulates the exp...

Emerging biomedical and pharmaceutical strategies for the treatment of atherosclerosis: from conventional lipid-lowering therapy to nanomedicine.

Journal of applied biomedicine 2026-06-01 浏览 41 动脉粥样硬化

Atherosclerotic cardiovascular disease (ASCVD), including myocardial infarction and ischemic stroke, is a leading cause of death and disability worldwide and is expected to rise further by 2030. Once ...

DOI 原文

A Review of Dietary and Nutritional Supplements Used to Promote Cardiovascular Health.

Journal of avian medicine and surgery 2026-06-01 浏览 19 动脉粥样硬化

Cardiovascular disease is frequently diagnosed in birds that are presented to veterinary hospitals, and atherosclerosis is a common cardiovascular condition identified in postmortem evaluations of pet...

DOI 原文

A new era in atherothrombosis.

Atherosclerosis 2026-06-01 浏览 47 动脉粥样硬化

Atherothrombosis is a complex vascular disorder in which a thrombus forms on a vascular lesion, typically following the disruption and/or erosion of an atherosclerotic plaque. Atherothrombosis is the ...

DOI 原文

Can markers predict plaque vulnerability?

Atherosclerosis 2026-06-01 浏览 43 动脉粥样硬化

The concept of "vulnerable plaque" (VP) has been evolving since its introduction as an atherosclerotic plaque prone to cause cardiovascular events, such as myocardial infarction and stroke. Once defin...

DOI 原文

Hematopoietic somatic mutations in atherosclerotic cardiovascular disease.

Atherosclerosis 2026-06-01 浏览 45 动脉粥样硬化

Age-related somatic mosaicism in the hematopoietic system is increasingly recognized as a risk factor for atherosclerotic cardiovascular disease. The most prominent example is clonal hematopoiesis of ...

DOI 原文

The secretory PCSK family in cardiovascular disease and beyond.

Atherosclerosis 2026-06-01 浏览 21 动脉粥样硬化

It took >20 years to discover the family of proteases implicated in the activation and/or regulation of the activity of secretory proteins, including polypeptide hormones, growth factors and receptors...

DOI 原文

FTO-Catalysed Demethylation of LUR1 mRNA Suppresses Macrophage Lipid Accumulation and Aortic Atherosclerosis.

Journal of cellular and molecular medicine 2026-06-01 浏览 25 动脉粥样硬化

Lipid deposition and foam cell formation drive atherogenesis. Lipid uptake regulator 1 (LUR1) and N6-methyladenosine (m6A) modification play key roles in systemic lipid homeostasis. Bioinformatic anal...

DOI 原文

Lipoprotein(a) and Peripheral Artery Disease as Independent Predictors of Arterial Stiffness in Patients With Hypertension: A Single-Center Cross-Sectional Study.

Journal of clinical hypertension (Greenwich, Conn.) 2026-06-01 浏览 45 动脉粥样硬化

Carotid-femoral pulse-wave velocity (cfPWV) is a marker of central arterial stiffness and an established predictor of cardiovascular risk in hypertension. Although elevated lipoprotein(a) [Lp(a)] conc...

DOI 原文

Role of nursing in the assessment of Peripheral Artery Disease: Comparison of two ankle to arm Index methods in patients with Diabetes.

Journal of vascular nursing : official publication of the Society for Peripheral Vascular Nursing 2026-06-01 浏览 53 动脉粥样硬化

AIMS: To compare the clinical implications of the new International Working Group on the Diabetic Foot (IWGDF) criterion for calculating the ankle-brachial index (ABI), which uses the lowest systolic ...

DOI 原文

Editor's Choice - Focused Update on Paclitaxel Coated Technologies, from the 2024 European Society for Vascular Surgery (ESVS) Guidelines on the Management of Asymptomatic Peripheral Arterial Disease and Intermittent Claudication.

European journal of vascular and endovascular surgery : the official journal of the European Society 2026-06-01 浏览 57 动脉粥样硬化

OBJECTIVE: This focused update to the European Society for Vascular Surgery (ESVS) clinical practice guidelines (CPGs) on asymptomatic peripheral arterial disease and intermittent claudication (IC) pr...

DOI 原文
第 9 / 15 页,共 0 篇
已选择 0 篇文献